1. Home
  2. EVOK vs ZBAI Comparison

EVOK vs ZBAI Comparison

Compare EVOK & ZBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • ZBAI
  • Stock Information
  • Founded
  • EVOK 2007
  • ZBAI 2015
  • Country
  • EVOK United States
  • ZBAI United States
  • Employees
  • EVOK N/A
  • ZBAI N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • ZBAI Professional Services
  • Sector
  • EVOK Health Care
  • ZBAI Consumer Discretionary
  • Exchange
  • EVOK Nasdaq
  • ZBAI Nasdaq
  • Market Cap
  • EVOK 5.4M
  • ZBAI 6.5M
  • IPO Year
  • EVOK 2013
  • ZBAI N/A
  • Fundamental
  • Price
  • EVOK $5.12
  • ZBAI $9.03
  • Analyst Decision
  • EVOK
  • ZBAI
  • Analyst Count
  • EVOK 0
  • ZBAI 0
  • Target Price
  • EVOK N/A
  • ZBAI N/A
  • AVG Volume (30 Days)
  • EVOK 432.5K
  • ZBAI 39.5K
  • Earning Date
  • EVOK 11-06-2025
  • ZBAI 11-12-2025
  • Dividend Yield
  • EVOK N/A
  • ZBAI N/A
  • EPS Growth
  • EVOK N/A
  • ZBAI N/A
  • EPS
  • EVOK N/A
  • ZBAI N/A
  • Revenue
  • EVOK $12,794,859.00
  • ZBAI $720,000.00
  • Revenue This Year
  • EVOK $57.38
  • ZBAI N/A
  • Revenue Next Year
  • EVOK $59.57
  • ZBAI N/A
  • P/E Ratio
  • EVOK N/A
  • ZBAI N/A
  • Revenue Growth
  • EVOK 70.02
  • ZBAI 44.00
  • 52 Week Low
  • EVOK $1.94
  • ZBAI $4.83
  • 52 Week High
  • EVOK $12.32
  • ZBAI $45.00
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 49.82
  • ZBAI 59.93
  • Support Level
  • EVOK $5.00
  • ZBAI $8.45
  • Resistance Level
  • EVOK $5.27
  • ZBAI $11.00
  • Average True Range (ATR)
  • EVOK 0.22
  • ZBAI 1.14
  • MACD
  • EVOK -0.05
  • ZBAI 0.44
  • Stochastic Oscillator
  • EVOK 38.91
  • ZBAI 53.74

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About ZBAI ATIF Holdings Limited Ordinary Shares

ATIF Holdings Ltd is a consulting company. It provides financial and advisory services to small and medium-sized enterprises and also to individual customers and families. The firm also offers Pre-IPO's, and Post-IPO's services. It operates in one operating segment which is the consulting service business. It generates the majority of its revenue from the USA.

Share on Social Networks: